Enanta Pharmaceuticals
ENTA
#8060
Rank
โ‚ฌ0.33 B
Marketcap
11,63ย โ‚ฌ
Share price
4.27%
Change (1 day)
14.01%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚ฌ43.27 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ65.25 Million. In 2025 the company made an earning of -โ‚ฌ56.44 Million, an increase over its 2024 earnings that were of -โ‚ฌ85.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ43.27 Million-23.33%
2025 -โ‚ฌ56.44 Million-34.07%
2024 -โ‚ฌ85.6 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.11 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ58.96 Million-407.13%
2019 โ‚ฌ19.19 M-78.63%
2018 โ‚ฌ89.83 M117.97%
2017 โ‚ฌ41.21 M-574.65%
2016 -โ‚ฌ8.69 Million-110.83%
2015 โ‚ฌ80.19 M-4.5%
2014 โ‚ฌ83.97 M-638.53%
2013 -โ‚ฌ15.6 Million-137.98%
2012 โ‚ฌ41.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.12 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.69 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ7.67 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.45 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.78 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.50 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA